Edwards Lifesciences Corp
EW
$86.69+0.28%
Delayed · as of Oct 15, 2026, 1:43 PM ET
Mkt cap
$49.91B
EV/Sales
7.84
P/E ratio
50.4
FY2025 Revenue
$6.07B
EPS (TTM)
$1.72
Gross Margin (FY2025)
78.01%
Profit Margin (FY2025)
17.69%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported EW revenue for 2025-12-31 was $6.07B. Net income was $1.07B. Revenue was up 1.0% from 2023-12-31 to 2025-12-31. EW currently screens at market cap $49.91B and trailing P/E 50.4.
Use this EW research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full EW income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Edwards Lifesciences Corp (EW) is a medical devices company in the Healthcare sector.
Latest cached Edwards Lifesciences Corp (EW) revenue for Dec 31, 2025 was $6.07B. Net income was $1.07B. Statements: https://lician.com/financials/ew
Edwards Lifesciences Corp (EW) trailing P/E is 50.4 on the latest cached fundamentals snapshot.
Edwards Lifesciences Corp (EW) market capitalization is $49.91B on the latest cached snapshot.
Edwards Lifesciences Corp (EW) cached previous close $86.45; day range $86.62 – $86.69; volume 1,320,740. Session quote: https://lician.com/quote/ew
Edwards Lifesciences Corp (EW) latest cached earnings event is "EW earnings" on Jul 23, 2026. Earnings calendar: https://lician.com/earnings
The latest cached EW filing is 8-K · Aug 28, 2026. Filings: https://lician.com/sec/ew